Skip to main content
. 2015 Jul 24;10(7):e0134051. doi: 10.1371/journal.pone.0134051

Fig 4. WB403 improved hyperglycemia of HFD/STZ mice.

Fig 4

Mice were treated with different concentration of WB403, vehicle or sitagliptin. FBG (A) and PBG (B) were measured every week during the 8-week treatment period. (C, D) HbA1c levels in serum. Values are mean ± SEM (n = 8). *p<0.05, **p<0.01, ***p<0.001 vs. vehicle group.